Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lupus Erythematosus, Systemic × sotrovimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

COVID-19 2 Vasculitis 1 Neoplasms 1 Lupus Erythematosus, Systemic 1 Hematologic Neoplasms 1 Glomerulonephritis 1

Interventions

Nivolumab 2 sotrovimab 1 gusacitinib 1 ciclesonide 1 anifrolumab 1 Standard of Care 1 Specimen Handling 1 Procalcitonin 1 Practice Guidelines as Topic 1 Niclosamide 1 Methods 1 Interviews as Topic 1 Immune Checkpoint Inhibitors 1 High-Intensity Interval Training 1 Exercise 1 Educational Status 1 Early Intervention, Educational 1 Cholecalciferol 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04870333 2025-06-20

PROTECT-V

Cambridge University Hospitals NHS Foundation Trust

Phase 2/3 Completed

COVID-19, Glomerulonephritis, Lupus Erythematosus, Systemic, Neoplasms, Vasculitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡